Association between smoking at diagnosis and cause-specific survival in patients with rectal cancer: Results from a population-based analysis of 10,794 cases

Cancer

Volumn 123, Issue 13, 2017, Pages 2543-2550

  Sharp, Linda ^a   McDevitt, Joseph ^b   Brown, Christopher ^b   Carsin, Anne Elie ^c   Comber, Harry ^b  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b NATIONAL CANCER REGISTRY IRELAND   (Ireland)

^c CENTRE FOR RESEARCH IN ENVIRONMENTAL EPIDEMIOLOGY CREAL   (Spain)

Author keywords

mortality; rectal cancer; smoking; survival; tobacco

Indexed keywords

ADULT; AGED; ARTICLE; CANCER REGISTRY; CANCER SURVIVAL; COHORT ANALYSIS; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; PRIORITY JOURNAL; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; RECTUM CANCER; SEX DIFFERENCE; SMOKING; ABDOMINAL SURGERY; ADENOCARCINOMA; CAUSE OF DEATH; EPIDEMIOLOGY; IRELAND; MIDDLE AGED; MORTALITY; MULTIVARIATE ANALYSIS; PATHOLOGY; RADIOTHERAPY; RECTAL NEOPLASMS; RECTUM; REGISTER; RISK FACTOR; SURGERY; SURVIVAL RATE;

ANTINEOPLASTIC AGENT;

ADENOCARCINOMA; AGED; ANTINEOPLASTIC AGENTS; CAUSE OF DEATH; COHORT STUDIES; DIGESTIVE SYSTEM SURGICAL PROCEDURES; FEMALE; HUMANS; IRELAND; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RADIOTHERAPY; RECTAL NEOPLASMS; RECTUM; REGISTRIES; RISK FACTORS; SEX FACTORS; SMOKING; SURVIVAL RATE;

EID: 85015311109     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.30583     Document Type: Article

References (52)

1. De Angelis R, Sant M, Coleman MP, et al. Cancer survival in Europe 1999-2007 by country and age: results of EUROCARE-5—a population-based study. Lancet Oncol. 2014;15:23-34.
2. Møller H, Sandin F, Robinson D, et al. Colorectal cancer survival in socioeconomic groups in England: variation is mainly in the short term after diagnosis. Eur J Cancer 2012;48:46-53.
3. Rutter CM, Johnson EA, Feuer EJ, Knudsen AB, Kuntz KM, Schrag D. Secular trends in colon and rectal cancer relative survival. J Natl Cancer Inst. 2013;105:1806-1813.
4. Hines R, Markossian T, Johnson A, Dong F, Bayakly R. Geographic residency status and census tract socioeconomic status as determinants of colorectal cancer outcomes. Am J Public Health. 2014;104:e63-e71.
5. World Cancer Research Fund International. Diet, Nutrition, Physical Activity and Breast Cancer Survivors. London, UK: World Cancer Research Fund; 2014.
6. US Department of Health and Human Services. The Health Consequences of Smoking—50 Years of Progress: A Report of the Surgeon General, 2014. Rockville, MD: US Department of Health and Human Services; 2014.
7. Liang PS, Chen TY, Giovannucci E. Cigarette smoking and colorectal cancer incidence and mortality: systematic review and meta-analysis. Int J Cancer. 2009;124:2406-2415.
8. International Agency for Research on Cancer. IARC Monographs on the evaluation of carcinogenic risks to humans. Volume 100E. Lyon, France: IARC; 2012.
9. Walter V, Jansen L, Hoffmeister M, Brenner H. Smoking and survival of colorectal cancer patients: systematic review and meta-analysis. Ann Oncol. 2014;25:1517-1525.
10. Morrison DS, Batty GD, Kivimaki M, Davey Smith G, Marmot M, Shipley M. Risk factors for colonic and rectal cancer mortality: evidence from 40 years' follow-up in the Whitehall I study. J Epidemiol Community Health. 2011;65:1053-1058.
11. Phipps AI, Baron J, Newcomb PA. Prediagnostic smoking history, alcohol consumption, and colorectal cancer survival: the Seattle Colon Cancer Family Registry. Cancer. 2011;117:4948-4957.
12. Boyle T, Fritschi L, Platell C, Heyworth J. Lifestyle factors associated with survival after colorectal cancer diagnosis. Cancer Causes Control. 2011;22:1647-1658.
13. Parajuli R, Bjerkaas E, Tverdal A, Le Marchand L, Weiderpass E, Gram IT. Cigarette smoking and colorectal cancer mortality among 602,242 Norwegian males and females. Clin Epidemiol. 2014;6:137-145.
14. Pelser C, Arem H, Pfeiffer RM, et al. Prediagnostic lifestyle factors and survival after colon and rectal cancer diagnosis in the National Institutes of Health (NIH)-AARP Diet and Health Study. Cancer. 2014;120:1540-1547.
15. Zhu Y, Yang SR, Wang PP, et al. Influence of pre-diagnostic cigarette smoking on colorectal cancer survival: overall and by tumor molecular phenotype. Br J Cancer. 2014;110:1359-1366.
16. Walter V, Jansen L, Hoffmeister M, Ulrich A, Chang-Claude J, Brenner H. Smoking and survival of colorectal cancer patients: Population-based study from Germany. Int J Cancer. 2015;137:1433-1445.
17. Nickelsen TN, Jørgensen T, Kronborg O. Lifestyle and 30-day complications to surgery for colorectal cancer. Acta Oncol. 2005;44:218-223.
18. Richards CH, Platt JJ, Anderson JH, McKee RF, Horgan P, McMillan DC. The impact of perioperative risk, tumor pathology and surgical complications on disease recurrence following potentially curative resection of colorectal cancer. Ann Surg. 2011;254:83-89.
19. Moral M, Fdez-Aceñero MJ, Cuberes R, Suárez A. Factors influencing prognosis after neo-adjuvant chemoradiation therapy for rectal carcinoma. Acta Chir Belg. 2009;109:345-351.
20. O'Brien K, Comber H, Sharp L. Completeness of case ascertainment at the Irish National Cancer Registry. Ir J Med Sci. 2014;183:219-224.
21. Howlader N, Ries LA, Mariotto AB, Reichman ME, Ruhl J, Cronin KA. Improved estimates of cancer-specific survival rates from population-based data. J Natl Cancer Inst. 2010;102:1584-1598.
22. Kelly A, Telijeur C. A new National deprivation index for health and health services research—short report. SAHRU Technical Report. Dublin, Ireland: Trinity College Dublin; 2004.
23. Massacesi C, Norman A, Price T, Hill M, Ross P, Cunningham D. A clinical nomogram for predicting long-term survival in advanced colorectal cancer. Eur J Cancer. 2000;36:2044-2052.
24. National Cancer Intelligence Network. NCIN Data Briefing. Colorectal cancer by stage. London, UK: National Cancer Intelligence Network; 2009.
25. White IR, Royston P, Wood AM. Multiple imputation using chained equations: Issues and guidance for practice. Stat Med. 2011;30:377-399.
26. White IR, Carlin JB. Bias and efficiency of multiple imputation compared with complete-case analysis for missing covariate values. Stat Med. 2010;29:2920-2931.
27. Rubin DB. Multiple imputation for non-response in surveys. New York: Wiley; 1987.
28. Brugha R, Tully N, Dicker P, Shelley E, Ward M, McGee H. SLÁN 2007: Survey of Lifestyle, Attitudes and Nutrition in Ireland. Smoking Patterns in Ireland: Implications for policy and services. Department of Health and Children. Dublin, Ireland: The Stationery Office; 2009.
29. National Cancer Registry/Northern Ireland Cancer Registry. All-Ireland cancer atlas 1995-2007. Cork/Belfast, Ireland: National Cancer Registry/Northern Ireland Cancer Registry; 2011.
30. Everhart J, Ferketich AK, Browning K, Wewers ME. Acculturation and misclassification of tobacco use status among Hispanic men and women in the United States. Nicotine Tob Res. 2009;11:240-247.
31. Wallner-Liebmann SJ, Grammer TB, Siekmeier R, Mangge H, März W, Renner W. Smoking denial in cardiovascular disease studies. Adv Exp Med Biol. 2013;788:35-38.
32. Peters SA, Huxley RR, Woodward M. Do smoking habits differ between women and men in contemporary Western populations? Evidence from half a million people in the UK Biobank study BMJ Open. 2014;4:e005663.
33. Park ER, Japuntich SJ, Rigotti NA, et al. A snapshot of smokers after lung and colorectal cancer diagnosis. Cancer. 2012;118:3153-3164.
34. Conroy MC, Morgan K, Curry P, et al. The clustering of health behaviours in Ireland and their relationship with mental health, self-rated health and quality of life. BMC Public Health. 2011;11:692.
35. Cai S, Li Y, Ding Y, Chen K, Jin M. Alcohol drinking and the risk of colorectal cancer death: a meta-analysis. Eur J Cancer Prev. 2014;23:532-536.
36. Fedirko V, Romieu I, Aleksandrova K, et al. Pre-diagnostic anthropometry and survival after colorectal cancer diagnosis in Western European populations. Int J Cancer. 2014;135:1949-1960.
37. Fracasso M, Doria D, Franceschetti P, Perbellini L, Romeo L. DNA damage and repair capacity by comet assay in lymphocytes of white-collar active smokers and passive smokers (non- and ex-smokers) at workplace. Toxicol Lett. 2006;167:131-141.
38. Lai CY, Hsieh LL, Sung FC, et al. Tumor site- and stage-specific associations between allelic variants of glutathione S-transferase and DNA-repair genes and overall survival in colorectal cancer patients receiving 5-fluorouracil-based chemotherapy. PloS One. 2013;8:e69039.
39. Russo AL, Thiagalingam A, Pan H, et al. Differential DNA hypermethylation of critical genes mediates the stage-specific tobacco smoke-induced neoplastic progression of lung cancer. Clin Cancer Res. 2005;11:2466-2470.
40. Benard A, Zeestraten EC, Goossens-Beumer IJ, et al. DNA methylation of apoptosis genes in rectal cancer predicts patient survival and tumor recurrence. Apoptosis. 2014;19:1581-1593.
41. Gaedcke J, Leha A, Claus R, et al. Identification of a DNA methylation signature to predict disease-free survival in locally advanced rectal cancer. Oncotarget. 2014;5:8123-8135.
42. Kohonen-Corish MR, Tseung J, Chan C, et al. KRAS mutations and CDKN2A promoter methylation show an interactive adverse effect on survival and predict recurrence of rectal cancer. Int J Cancer. 2014;134:2820-2828.
43. Yanbaeva D, Dentener M, Creutzberg EC, Wesseling G, Wouters E. Systemic effects of smoking. Chest. 2007;131:1557-1566.
44. O'Byrne K, Dalgleish A, Browning M, Steward W, Harris A. The relationship between angiogenesis and the immune response in carcinogenesis and the progression of malignant disease. Eur J Cancer. 2000;36:151-169.
45. Slattery ML, Wolff RK, Herrick J, Caan BJ, Samowitz W. Tumor markers and rectal cancer: support for an inflammation-related pathway. Int J Cancer. 2009;125:1698-1704.
46. Carruthers R, Tho LM, Brown J, Kakumanu S, McCartney E, McDonald AC. Systemic inflammatory response is a predictor of outcome in patients undergoing preoperative chemoradiation for locally advanced rectal cancer. Colorectal Dis. 2012;14:e701-e707.
47. McMillan DC, Crozier JE, Canna K, Angerson WJ, McArdle CS. Evaluation of an inflammation-based prognostic score (GPS) in patients undergoing resection for colon and rectal cancer. Int J Colorectal Dis. 2007;22:881-886.
48. Morales NA, Romano MA, Cummings KM, Marshall JR, Hyland AJ, Hutson A, Warren GW. Accuracy of self-reported tobacco use in newly diagnosed cancer patients. Cancer Causes Control. 2013;24:1223-1230.
49. Tammemagi CM, Neslund-Dudas C, Simoff M, Kvale P. In lung cancer patients, age, race-ethnicity, gender and smoking predict adverse comorbidity, which in turn predicts treatment and survival. J Clin Epidemiol. 2004;57:597-609.
50. Roulson J, Benbow EW, Hasleton PS. Discrepancies between clinical and autopsy diagnosis and the value of post mortem histology; a meta-analysis and review. Histopathology. 2005;47:551-559.
51. Blakely T, Soeberg M, Carter K, Costilla R, Atkinson J, Sarfati D. Bias in relative survival methods when using incorrect life-tables: lung and bladder cancer by smoking status and ethnicity in New Zealand. Int J Cancer. 2012;131:E974-E979.
52. American College of Surgeons. National Cancer Database. Available at http://oliver.facs.org/BMPub/index.cfm. Accessed September 5, 2016.